Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

C-Maf T-cell switch factor: Important component of Boston Life Science's R&D

July 19, 1996

Genome Therapeutics and Merck & Co. sign licensing agreement

July 19, 1996

Roche licenses PCR technology to Immuno

July 12, 1996

GenPharm describes high-affinity human IgG monoclonal antibodies

July 12, 1996

LCR Technology covered under U.S. patent

July 12, 1996

SmithKline Beecham/Human Genome Sciences human genome collaboration no longer exclusive

July 12, 1996

Oculex receives grants for ocular drug delivery research

July 12, 1996

Heliosynthese and Scotia receive EEC Eureka award for microalgae research

July 12, 1996

Phytera and Tsumura Juntendo collaborate in rheumatoid arthritis/allergy R&D

July 12, 1996

Collaboration on signal transduction inhibitor drug discovery announced

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
Research grants support early clinical trials of ALS treatments
BioWorld Science
The ALS Association has announced the recipients of its 2025 Hoffman ALS Clinical Trial Awards. These research grants, worth up to $1 million each, support...